Cover image for Prime Therapeutics prioritizes patient-centered care, stays ahead of oncology trends Prime simplifies the cancer care pathway through innovative solutions that help manage complex...

New Biosimilars First Generic Drug Launches Oct. 25, 2024 - sulopenem etzadroxil and probenecid (Orlynvah) The FDA has approved Iterum’s Orlynvah for the treatment of uncomplicated urinary tract...

Managed Markets Insight & Technology (MMIT)

Read Part 1 – Payer Survey Dive into Part 1 Hear from Prime’s medical pharmacy experts as they dive into the history of the report and offer their insights. Check out the events below to stay...